{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:58:47Z","timestamp":1769007527763,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ijcard.2015.04.189","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T18:21:10Z","timestamp":1429986070000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-5781","authenticated-orcid":false,"given":"Satoru","family":"Sakuragi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Tanakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.04.189_bb0005","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","article-title":"Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention","volume":"27","author":"Levin","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-72-6-813","article-title":"Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study","volume":"72","author":"Kannel","year":"1970","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0020","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/01.CIR.103.19.2346","article-title":"Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men","volume":"103","author":"Sundstrom","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.1990.182","article-title":"Measurement of renal function in chronic renal disease","volume":"38","author":"Levey","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.11.044","article-title":"Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy","volume":"62","author":"Pavkov","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.108.807271","article-title":"Association of cystatin C with left ventricular structure and function: the Dallas Heart Study","volume":"2","author":"Patel","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension","volume":"114","author":"Koren","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0055","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0060","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0065","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0735-1097(97)00344-6","article-title":"Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures","volume":"30","author":"Nagueh","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0070","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0075","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/0735-1097(92)90617-V","article-title":"Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension","volume":"19","author":"Ganau","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0080","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0090","first-page":"47","article-title":"Cystatin C\u2014a paradigm of evidence based laboratory medicine","volume":"29","author":"Chew","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0095","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.jacc.2013.08.1622","article-title":"Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes","volume":"62","author":"Poulsen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0100","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue Doppler imaging a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0105","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0110","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00018-004-4445-9","article-title":"Proteinaceous cysteine protease inhibitors","volume":"62","author":"Dubin","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0120","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","article-title":"Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cvr\/cvq138","article-title":"Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation","volume":"87","author":"Xie","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.HYP.0000242331.99369.2f","article-title":"Elastolytic cathepsin induction\/activation system exists in myocardium and is upregulated in hypertensive heart failure","volume":"48","author":"Cheng","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.04.189_bb0135","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0140","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0145","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/HJH.0b013e32833d95fe","article-title":"Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk","volume":"28","author":"Tsioufis","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cardfail.2005.06.001","article-title":"Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure","volume":"11","author":"Arimoto","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.04.189_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315009225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315009225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T01:58:02Z","timestamp":1537667882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315009225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":31,"alternative-id":["S0167527315009225"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.189","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}